Mon, Nov 30, 2015
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index Gains 11.21% in 2013; Equity Short Bias Index Suffers Record Loss of 27.15%

Wednesday, January 15, 2014
Opalesque Industry Update - Hedge funds gained 1.23% in December, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index gained 11.21% in 2013.

“The US Fed announced in December that it would reduce Quantitative Easing purchases from $85 billion to $75 billion per month, and assured market participants that until certain growth rates and unemployment levels were achieved, interest rates would remain low,” says Sol Waksman, founder and president of BarclayHedge.

“Equity prices in the US and Europe rallied on the news and the S&P 500 reached a record high on the final trading day of the year."

Overall, 17 of Barclay’s 18 hedge fund indices had gains in December. The Barclay Technology Index gained 2.05%, Pacific Rim Equities were up 2.05%, Equity Long Bias gained 1.98%, the Healthcare & Biotechnology Index was up 1.91%, Equity Long/Short rose 1.72%, and Distressed Securities added 0.97%.

The leading hedge fund index in 2013 was Healthcare & Biotechnology, which gained 28.98%. Pacific Rim Equities were up 23.14%, Equity Long Bias Index returned 21.52%, and Distressed Securities gained 16.62% for the year.

The Equity Short Bias Index fell 2.46% in December, and was the only hedge fund strategy with a loss in 2013. Short Bias ended the year 27.15% in the red, surpassing last year’s record loss of 24.12%.

“The S&P 500 had its best year since 1997 when it gained 33.38 percent,” says Waksman. “For traders on the short side of the market, swimming against a strong current can be treacherous.”

The Barclay Fund of Funds Index gained 1.08% in December, and was up 8.46% in 2013.


Press Release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Hedge fund marketing and the selling cycle[more]

    By Bruce Frumerman. How long is the selling cycle now? That’s a question my financial communications and sales marketing consulting firm has been asked on a regular basis by hedge fund firm owners and sales people, ever since we opened the doors to our firm in 1987 pre-crash. Wa

  2. People - Solus Alternative Asset Management adds chief strategist from BTIG[more]

    From Daniel Greenhaus joined hedge fund manager Solus Alternative Asset Management as managing director and chief strategist. He will work closely with Chris Bondy, Solus’ chief economist, managing director and executive vice president, said Chris Pucillo, CEO and chief investmen

  3. Opalesque Roundtable: Seeding deal terms can be onerous for hedge funds[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Executives from fund of funds firms, family offices, a placement agent, a private equity firm, and an accounting firm gathered in Connecticut last month for the

  4. Opalesque Roundtable: Family offices flock to co-investment[more]

    Bailey McCann, Opalesque New York: Co-investments have been a hot topic for pension funds in recent years, as they try to move away from high fees and improve transparency. But now, family offices are more readily getting into the mix and establishing in-house deal teams, according to the delega

  5. More institutional investors invest in CTAs compared to last year despite dissatisfaction with performance[more]

    Benedicte Gravrand, Opalesque Geneva: "Despite a strong start to 2015 for CTAs in Q1, commodity market conditions have made return generation difficult for fund managers over much of the rest of the year to date," says Preqin’s November